Metronomic chemotherapy in the neoadjuvant setting: results of two parallel feasibility trials (TraQme and TAME) in patients with HER2+ and HER2− locally advanced breast cancer (2015)
- Authors:
- USP affiliated authors: MANO, MAX SENNA - FM ; HOFF, PAULO MARCELO GEHM - FM
- Unidade: FM
- DOI: 10.1590/1414-431x20144354
- Subjects: QUIMIOTERAPIA ADJUVANTE; ENSAIO CLÍNICO CONTROLADO RANDOMIZADO; NEOPLASIAS MAMÁRIAS
- Language: Inglês
- Imprenta:
- Source:
- Título: Brazilian Journal of Medical and Biological Research
- ISSN: 1414-431X
- Volume/Número/Paginação/Ano: v. 48, n. 5, p. 479-485, 2015
- Status:
- Artigo publicado em periódico de acesso aberto (Gold Open Access)
- Versão do Documento:
- Versão publicada (Published version)
- Acessar versão aberta:
-
ABNT
PETRY, V. et al. Metronomic chemotherapy in the neoadjuvant setting: results of two parallel feasibility trials (TraQme and TAME) in patients with HER2+ and HER2− locally advanced breast cancer. Brazilian Journal of Medical and Biological Research, v. 48, n. 5, p. 479-485, 2015Tradução . . Disponível em: https://doi.org/10.1590/1414-431x20144354. Acesso em: 13 abr. 2026. -
APA
Petry, V., Gagliato, D. M., Leal, A. I. C., Arai, R. J., Longo, E., Andrade, F., et al. (2015). Metronomic chemotherapy in the neoadjuvant setting: results of two parallel feasibility trials (TraQme and TAME) in patients with HER2+ and HER2− locally advanced breast cancer. Brazilian Journal of Medical and Biological Research, 48( 5), 479-485. doi:10.1590/1414-431x20144354 -
NLM
Petry V, Gagliato DM, Leal AIC, Arai RJ, Longo E, Andrade F, Ricci MD, Piato JR, Barroso-Sousa R, Hoff PM, Mano MS. Metronomic chemotherapy in the neoadjuvant setting: results of two parallel feasibility trials (TraQme and TAME) in patients with HER2+ and HER2− locally advanced breast cancer [Internet]. Brazilian Journal of Medical and Biological Research. 2015 ; 48( 5): 479-485.[citado 2026 abr. 13 ] Available from: https://doi.org/10.1590/1414-431x20144354 -
Vancouver
Petry V, Gagliato DM, Leal AIC, Arai RJ, Longo E, Andrade F, Ricci MD, Piato JR, Barroso-Sousa R, Hoff PM, Mano MS. Metronomic chemotherapy in the neoadjuvant setting: results of two parallel feasibility trials (TraQme and TAME) in patients with HER2+ and HER2− locally advanced breast cancer [Internet]. Brazilian Journal of Medical and Biological Research. 2015 ; 48( 5): 479-485.[citado 2026 abr. 13 ] Available from: https://doi.org/10.1590/1414-431x20144354 - Malignancy-related hypercalcemia in the bishosphonate era
- Serum levels of VEGF and MCSF in HER2+/HER2- breast cancer patients with metronomic neoadjuvant chemotherapy
- Rare tumors research in emerging countries
- Ascite quilosa em paciente com carcinoma ductal invasivo de mama
- Câncer de mama HER2 positivo: tratamento (NEO) adjuvante - análise das pacientes tratadas no ICESP
- Feasibility of two schedules of weekly paclitaxel in HER2-negative early breast cancer in a Brazilian community setting
- Carcinoma neuroendócrino primário de mama (CNEM) - um diagnóstico raro: relato de dois casos
- A Phase II Randomized Study of Lapatinib Combined With Capecitabine, Vinorelbine, or Gemcitabine in Patients With HER2-Positive Metastatic Breast Cancer With Progression After a Taxane (Latin American Cooperative Oncology Group 0801 Study)
- HER2-targeted therapy in breast cancer: A systematic review of neoadjuvant trials
- Value of systemic staging in asymptomatic early breast cancer
Informações sobre a disponibilidade de versões do artigo em acesso aberto coletadas automaticamente via oaDOI API (Unpaywall).
Por se tratar de integração com serviço externo, podem existir diferentes versões do trabalho (como preprints ou postprints), que podem diferir da versão publicada.
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
